{"id":"salicylanilide","rwe":[{"pmid":"41873670","year":"2026","title":"Photoregulated Sequential Chemical Relay via Artificial Nanochannels.","finding":"","journal":"ACS applied bio materials","studyType":"Clinical Study"},{"pmid":"41786695","year":"2026","title":"Rafoxanide disrupts mitochondrial homeostasis through VDAC1 modulation in colorectal cancer cells.","finding":"","journal":"Cell death discovery","studyType":"Clinical Study"},{"pmid":"41775841","year":"2026","title":"Collective synthesis of 1,2,4-trisubstituted, meta- and ortho-substituted arene bioisosteres from bicyclobutanes.","finding":"","journal":"Nature chemistry","studyType":"Clinical Study"},{"pmid":"40722758","year":"2025","title":"Repurposing Rafoxanide: From Parasite Killer to Cancer Fighter.","finding":"","journal":"Biomedicines","studyType":"Clinical Study"},{"pmid":"40446543","year":"2025","title":"Computer-aided drug discovery of a dual-target inhibitor for ovarian cancer: therapeutic intervention targeting CDK1/TTK signaling pathway and structural insights in the NCI-60.","finding":"","journal":"Computers in biology and medicine","studyType":"Clinical Study"}],"tags":[{"label":"salicylanilide","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"}],"phase":"unknown","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"ansadol","offLabel":[],"synonyms":["salicylanilide","2-Hydroxy-N-phenylbenzamide","ansadol","N-Phenylsalicylamide","salicylanilid","salicylic acid anilide","salifebrin","salinide","salinidol","salnide"],"timeline":[],"approvals":[],"brandName":"Ansadol","ecosystem":[],"mechanism":{"modality":"Small Molecule","drugClass":"salicylanilide","explanation":"Imagine Ansadol as a key that fits into a lock in our cells. When it binds to its target, it can turn on or off certain cellular processes, which can help to treat a variety of diseases. However, the exact lock and key mechanism of Ansadol is still a mystery.","oneSentence":"Ansadol is thought to work by modulating a specific biological pathway, although the exact mechanism is not well understood.","technicalDetail":"Ansadol's mechanism of action is likely to involve the inhibition or activation of a specific enzyme or receptor, although the precise molecular details are unknown."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/3539","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=salicylanilide","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T15:34:55.233813","biosimilars":[],"competitors":[],"genericName":"salicylanilide","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"NDDF":"002907","UNII":"LHP8NEY345","CHEBI":"CHEBI:239133","UMLSCUI":"C0036074","ChEMBL_ID":"CHEMBL82970","PDB_CHEM_ID":" SLI","PUBCHEM_CID":"6872","SNOMEDCT_US":"60905001","MESH_SUPPLEMENTAL_RECORD_UI":"C034596"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":284,"therapeuticAreas":["Other"],"biosimilarFilings":[],"recentPublications":[{"date":"2026 Mar 24","pmid":"41873670","title":"Photoregulated Sequential Chemical Relay via Artificial Nanochannels.","journal":"ACS applied bio materials"},{"date":"2026 Mar 5","pmid":"41786695","title":"Rafoxanide disrupts mitochondrial homeostasis through VDAC1 modulation in colorectal cancer cells.","journal":"Cell death discovery"},{"date":"2026 Mar 3","pmid":"41775841","title":"Collective synthesis of 1,2,4-trisubstituted, meta- and ortho-substituted arene bioisosteres from bicyclobutanes.","journal":"Nature chemistry"},{"date":"2025 Jul 9","pmid":"40722758","title":"Repurposing Rafoxanide: From Parasite Killer to Cancer Fighter.","journal":"Biomedicines"},{"date":"2025 Jul","pmid":"40446543","title":"Computer-aided drug discovery of a dual-target inhibitor for ovarian cancer: therapeutic intervention targeting CDK1/TTK signaling pathway and structural insights in the NCI-60.","journal":"Computers in biology and medicine"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"unknown","modality":"Small Molecule","firstApprovalDate":"","aiSummary":"Ansadol is a chemical compound classified as both a salicylamide and an anilide, being the amide of salicylic acid and aniline. It is composed of salicylic acid and aniline combined through an amide bond.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}